Insulin vials vs. insulin cartridges: Further cost considerations

Saudi Pharmaceutical Journal

Volumn 21, Issue 2, 2013, Pages 225-227

  Al Sharayri, Mohammad G ^a   Alsabrah, Tariq M ^b   Aljbori, Tareq M ^b   Abu Rumman, Ala'a Eddeen K ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Cartridge; Cost; Insulin; Vial; Wastage

Indexed keywords

INSULIN;

ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG COST; DRUG FORMULATION; DRUG STORAGE; HUMAN; OUTPATIENT; PHARMACY; PRESCRIPTION;

EID: 84875811094     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2012.07.003     Document Type: Article

References (5)

1. Baser O., Bouchard J., DeLuzio T., Henk H., Aagren M. Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe. Adv. Ther. 2010, 27(2):94-104.
2. Bohannon N. Insulin delivery using pen devices: simple-to-use tools may help young and old alike. Postgrad. Med. 1999, 106(5):57-68.
3. Meece J. Effect of insulin pen devices on the management of diabetes mellitus. Am. J. Health Syst. Pharm. 2008, 65:1076-1082.
4. Rakel R. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Adv. Ther. 2009, 26(9):838-846.
5. Ward L., Aton S. Impact of an interchange program to support use of insulin pens. Am. J. Health Syst. Pharm. 2011, 68:1349-1352.